BioSpace News Archive

Align Technology, Inc. (Align) (Nasdaq: ALGN) today announced the creation of a combined product innovation and marketing organization

CV Sciences, Inc. (OTCQB:CVSI) (the “Company”, “CV Sciences”, “our”, “us” or “we”), a preeminent supplier and manufacturer of hemp cannabidiol (CBD) products, today announced that it will now release financial results for the year ended December 31, 2019, after the stock market closes on Monday, March 16, 2020

The Janssen Pharmaceutical Companies of Johnson & Johnson announced today that the U.S. Food and Drug Administration (FDA) has granted Breakthrough Therapy Designation for JNJ-61186372 (JNJ-6372) for the treatment of patients with metastatic non-small cell lung cancer (NSCLC) with epidermal growth factor receptor (EGFR) Exon 20 insertion mutations, whose disease has progressed on or after platinum-based chemotherapy

Protagonist Therapeutics, Inc. (Nasdaq:PTGX) today reported its financial results for the fourth quarter and full year ended December 31, 2019, and provided an update on its clinical development programs.

AngioDynamics, Inc. (NASDAQ: ANGO), a leading provider of innovative, minimally invasive medical devices for vascular access, peripheral vascular disease, and oncology, today announced that it will report financial results for the third quarter of fiscal year 2020 before the market open on Tuesday, April 7, 2020.

DermTech, Inc. (NASDAQ: DMTK) (“DermTech” or the “Company”), a leader in precision dermatology enabled by a non-invasive skin genomics platform, today reported business and financial results for the quarter and year ended December 31, 2019 and provided a corporate update. Recent Corporate Updates In January 2020, the Company contracted with a regional health plan to make its gene expression-based Pigment

PPD, Inc. (Nasdaq:PPD) today announced the cancellation of its fireside chat and related webcast at the Barclays Global Healthcare Conference, previously scheduled for Wednesday, March 11, at 11:45 a.m. (U.S. Eastern Time), as a result of the conference switching to a virtual format. About PPD PPD is a leading global contract research organization providing comprehensive, integrated drug development, labora

22nd Century Group, Inc. announced the appointment of Lisa Parks as its Vice President of Acquisitions and Mei Kuo as its new Director of Communications and Investor Relations.

Clinical data presented at 2019 American Society of Hematology (ASH) annual meeting suggested that CPI-0610 could offer meaningful benefits beyond standard of care in myelofibrosis In addition to previously expanded MANIFEST Cohorts 3 and 2A, now expanding Cohort 1A Planning update for MANIFEST and discussions with regulatory agencies about CPI-0610 around mid-year, additional MANIFEST update before yearend

TempTraq® single-use, wireless patch ideal for monitoring patient temperatures without need for direct patient contact